139 related articles for article (PubMed ID: 15969315)
1. [Is fibrinogen a predictor or a marker of the risk of cardiovascular events?].
Drouet L; Bal dit Sollier C
Therapie; 2005; 60(2):125-36. PubMed ID: 15969315
[TBL] [Abstract][Full Text] [Related]
2. [Fibrinogen: factor and marker of cardiovascular risk].
Drouet L; Bal Dit Sollier C
J Mal Vasc; 2002 Jun; 27(3):143-56. PubMed ID: 12232531
[TBL] [Abstract][Full Text] [Related]
3. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
4. [Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].
Drouet L; Bal dit Sollier C
Therapie; 2005; 60(2):137-47. PubMed ID: 15969316
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
Ernst E
Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen and cardiovascular risk.
Heinrich J; Assmann G
J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
[TBL] [Abstract][Full Text] [Related]
7. [Fibrinogen. Cardiovascular risk factor or marker?].
Canseco-Avila LM; Jerjes-Sánchez C; Ortiz-López R; Rojas-Martínez A; Guzmán-Ramírez D
Arch Cardiol Mex; 2006; 76 Suppl 4():S158-72. PubMed ID: 17469344
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and cardiovascular risk.
Ernst E; Koenig W
Vasc Med; 1997; 2(2):115-25. PubMed ID: 9546953
[TBL] [Abstract][Full Text] [Related]
9. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients.
Di Napoli M; Papa F;
Stroke; 2002 Jul; 33(7):1763-71. PubMed ID: 12105349
[TBL] [Abstract][Full Text] [Related]
10. Emerging noninvasive biochemical measures to predict cardiovascular risk.
Pahor M; Elam MB; Garrison RJ; Kritchevsky SB; Applegate WB
Arch Intern Med; 1999 Feb; 159(3):237-45. PubMed ID: 9989535
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of fibrinogen in carotid atherosclerosis: nonspecific indicator of inflammation or independent predictor of disease progression?
Sabeti S; Exner M; Mlekusch W; Amighi J; Quehenberger P; Rumpold H; Maurer G; Minar E; Wagner O; Schillinger M
Stroke; 2005 Jul; 36(7):1400-4. PubMed ID: 15933258
[TBL] [Abstract][Full Text] [Related]
12. Serum fibrinogen levels are an independent predictor of mortality in patients with chronic kidney disease (CKD) stages 3 and 4.
Goicoechea M; de Vinuesa SG; Gómez-Campderá F; Aragoncillo I; Verdalles U; Mosse A; Luño J
Kidney Int Suppl; 2008 Dec; (111):S67-70. PubMed ID: 19034331
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen and thrombophilia.
Golec DB
Clin Lab Sci; 2001; 14(4):269-71. PubMed ID: 11760826
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen and cardiovascular disease in clinical practice.
Fowkes FG
Eur Heart J; 1995 Mar; 16 Suppl A():60-3. PubMed ID: 7796834
[TBL] [Abstract][Full Text] [Related]
15. [Fibrinogen: cardiovascular risk factor].
Espinosa RA;
Invest Clin; 2002 Dec; 43(4):291-301. PubMed ID: 12521001
[TBL] [Abstract][Full Text] [Related]
16. Critical appraisal of inflammatory markers in cardiovascular risk stratification.
Krintus M; Kozinski M; Kubica J; Sypniewska G
Crit Rev Clin Lab Sci; 2014 Oct; 51(5):263-79. PubMed ID: 24918900
[TBL] [Abstract][Full Text] [Related]
17. Fibrin(ogen) in cardiovascular disease: an update.
Koenig W
Thromb Haemost; 2003 Apr; 89(4):601-9. PubMed ID: 12669113
[TBL] [Abstract][Full Text] [Related]
18. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
Hartmann M; von Birgelen C; Mintz GS; Stoel MG; Eggebrecht H; Wieneke H; Fahy M; Neumann T; van der Palen J; Louwerenburg HW; Verhorst PM; Erbel R
J Am Coll Cardiol; 2006 Aug; 48(3):446-52. PubMed ID: 16875967
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between inflammation marker and all-cause and cardiovascular mortality in a prospective cohort study].
Carbayo Herencia JA; Simarro Rueda M; Artigao Ródenas LM; Divisón Garrote JA; Caldevilla Bernardo D; Ponce García I; Sanchis Domènech C;
Clin Investig Arterioscler; 2013; 25(2):56-62. PubMed ID: 23849212
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo-Perin P;
Diabetologia; 2005 Mar; 48(3):427-34. PubMed ID: 15696295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
